Strep throat, something we've all had at some point in our lives, is caused by the bacteria Streptococcus pyogenes. Infection ...

Northwestern Medicine scientists have discovered new details about how the human genome produces instructions for creating ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Galderma, the pure-play dermatology category leader, is pioneering new research into the impact of medication-driven <a target=_ ...

Biomedical engineers at Duke University have developed an AI-based platform that designs short proteins, termed peptides, ...

Objective: To evaluate the effect of combination therapy with pioglitazone and glucagon-like peptide (GLP)-1 in patients with type 2 diabetes. Conclusions: GLP-1 and pioglitazone show an additive ...

Researchers from the Institute of Science Tokyo and Osaka Medical and Pharmaceutical University said that they have developed a peptide that can bind to the spike proteins of SARS-CoV-2 to prevent ...

Lipidated analogues of glucagon-like peptide 1 (GLP-1) have gained enormous attention ... This work provides a systematic study of the solubility, structure, oligomerization, and long-term stability ...

CCK denotes cholecystokinin, GI gastrointestinal, GLP-1 glucagon-like peptide 1, and PYY peptide YY. Hunger is controlled by redundant neuroendocrine circuitries that maintain metabolic balance.

a novel glucagon-like peptide-1 (GLP-1) receptor agonist medication, in those without diabetes. These findings suggest that insurance plan type and structure may be a crucial intervention point ...